International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 978-983 , 15 March 2010

Outcome After Conservative Surgery and Breast Irradiation in 5,717 Patients With Breast Cancer: Implications for Supraclavicular Nodal Irradiation

  • Lorenzo Livi, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
    • Corresponding Author InformationReprint requests to: Lorenzo Livi, M.D., Radiotherapy Unit, University of Florence, Viale Morgagni 85, 50134 Florence, Italy. Tel: (+39) 55-7947719; Fax: (+39) 55-437930
  • ,
  • Vieri Scotti, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Calogero Saieva, M.D.

      Affiliations

    • Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Center, Scientific Institute of Tuscany, Florence, Italy
  • ,
  • Icro Meattini, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Beatrice Detti, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Gabriele Simontacchi, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Carla Deluca Cardillo, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Fabiola Paiar, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Monica Mangoni, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Livia Marrazzo, Ph.D.

      Affiliations

    • Department of Medical Physics, University of Florence, Florence, Italy
  • ,
  • Benedetta Agresti, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy
  • ,
  • Luigi Cataliotti, M.D.

      Affiliations

    • Department of Surgery, University of Florence, Florence, Italy
  • ,
  • Simonetta Bianchi, M.D.

      Affiliations

    • Department of Pathology, University of Florence, Florence, Italy
  • ,
  • Giampaolo Biti, M.D.

      Affiliations

    • Radiotherapy Unit, University of Florence, Florence, Italy

Received 26 November 2008 ,Revised 26 February 2009 ,Accepted 2 March 2009.

References 

  1. Galimberti V. International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol. 2006;24:210–211
  2. Gentilini O, Botteri E, Rotmensz N, et al. Conservative surgery in patients with multifocal/multicentric breast cancer. Breast Cancer Res Treat. 2009;113:577–583
  3. Intra M, Rotmensz N, Mattar D, et al. Unnecessary axillary node dissections in the sentinel lymph node era. Eur J Cancer. 2007;43:2664–2668
  4. Belkacémi Y, Chauvet MP, Giard S, et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: Early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol. 2009;90:23–29
  5. Ivaldi GB, Leonardi MC, Orecchia R, et al. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women. Int J Radiat Oncol Biol Phys. 2008;72:485–493
  6. Livi L, Paiar F, Buonamici FB, et al. Accelerated intensity-modulated external radiotherapy as a new technical approach to treat the index quadrant after conserving surgery in early breast cancer: A preliminary study. Tumori. 2005;91:227–232
  7. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  8. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–955
  9. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group (DBCG) 82c randomised trial. Lancet. 1999;353:1641–1648
  10. Pierce LJ, Glatstein E. Postmastectomy radiotherapy in the management of operable breast cancer. Cancer. 1994;74:477–485
  11. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: An overview of the randomized trials. N Engl J Med. 1995;333:1444–1455
  12. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet. 2000;355:1757–1770
  13. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. 2001;93:978–979
  14. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiotherapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18:1220–1229
  15. Kingsmore DB, Hole DJ, Gillis CR, et al. Axillary recurrence in breast cancer. Eur J Oncol. 2005;31:226–231
  16. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection for level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer. 1992;28:1415–1418
  17. Strom EA, Woodward WA, Katz A, et al. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63:1508–1513
  18. International Commission of Radiation Units and Measurements. Dose specification for reporting external beam therapy with photons and electrons. Report 50. Bethesda, MD: ICRU; 1992;
  19. Hellman S. Stopping metastases at their source. N Engl J Med. 1997;337:996–997
  20. Koscielny S, Tubiana M. The link between local recurrence and distant metastases in human breast cancer. Int J Radiat Oncol Biol Phys. 1999;43:11–24
  21. Arriagada R, Lê MG. Adjuvant radiotherapy in breast cancer. The treatment of lymph node areas. Acta Oncol. 2000;39:295–305
  22. Mamounas EP. NSABP breast cancer clinical trials: Recent results and future directions. Clin Med Res. 2003;1:309–326
  23. Wang CW, Kuo WH, Chang KJ, et al. Should adjuvant radiotherapy to the supraclavicular fossa be routinely give in patients with breast conservative treatment?. J Surg Oncol. 2007;96:144–150
  24. Galimberti V, Leonardi MC, Rotmensz N, et al. Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology. Tumori. 2008;94:52–58
  25. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  26. Pergolizzi S, Adamo V, Russi E, et al. Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases. Int J Radiat Oncol Biol Phys. 2006;65:25–32
  27. Truong PT, Jones SO, Kader HA, et al. Patients with T1 to T2 breast cancer with one to three positive nodes have higher local and regional recurrence risk compared with node-negative patients after breast conserving surgery and whole breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:357–364
  28. Stranzl H, Ofner P, Peintinger F. Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumour extension on locoregional and distant control?. Strahlenther Onkol. 2006;182:583–588
  29. Truong PT, Olivotto IA, Whelan TJ, et al. Clinical practice guidelines for the care and treatment of breast cancer: 16. Loco-regional postmastectomy radiotherapy. CMAJ. 2004;170:1263–1273
  30. Ragaz J, Olivotto IA, Spinelli JJ, et al. Loco-regional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–126
  31. Danish Breast Cancer Cooperative GroupNielsen HM, Overgaard M, et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82b and c randomized studies. J Clin Oncol. 2006;24:2268–2275
  32. Whelan T, Levine M. More evidence that loco-regional radiation therapy improves survival: What should we do?. J Natl Cancer Inst. 2005;97:82–84
  33. Vicini FA, Horwitz EM, Lacerna MD, et al. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1997;39:1069–1076
  34. Grills IS, Kestin LL, Goldstein N, et al. Risk factors for regional nodal failure after breast-conserving therapy: Regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int J Radiat Oncol Biol Phys. 2003;56:658–670
  35. Ampil FL, Caldito G, Li BD, et al. Supraclavicular nodal relapse of breast cancer: Prevalence, palliation, and prognosis. Eur J Gynaecol Oncol. 2003;24:233–235
  36. Pejavar S, Wilson LD, Haffty BG. Regional node recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). Int J Radiat Oncol Biol Phys. 2006;66:1320–1327
  37. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet. 2005;365:1687–1717
  38. Coen JJ, Taghian AG, Kachnic LA, et al. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys. 2003;55:1209–1215
  39. Pierce SM, Recht A, Lingos TI, et al. Long term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23:915–923
  40. Chua B, Ung O, Boyages J. Competing considerations in regional nodal treatment for early breast cancer. Breast J. 2002;8:15–22
  41. Acharya CR, Hsu DS, Anders CK, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299:1574–1587

 Conflict of interest: none.

PII: S0360-3016(09)00359-9

doi: 10.1016/j.ijrobp.2009.03.001

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 4 , Pages 978-983 , 15 March 2010